@lovaltech

Lovaltech | 🧬 French biotech company specializing in the development of innovative nasal vaccines. Protecting the world, more effectively and more simply. 🛡️

 Tours
lovaltechnology.com/
Joined April 2026
  • Tweets36
  • Following99
  • Followers12
18Media
Lovaltech is : ✅ An exclusive global license 💰 €17 million in funding secured 🧬 A technology platform dedicated to nasal vaccination
1
1
29
🧪 A successfully completed Phase I clinical trial 📅 Phase II scheduled for November 2026 🚀 And other projects in progress and coming soon… #Deeptech #Vaccines #MucosalImmunity
🤖 Made with AI
4
27
Vous avez été des centaines à croire en nous sur @tudigoFR. Merci !🙏 La campagne de financement de Lovaltech se clôture avec succès. Votre soutien est le moteur de notre innovation. Nous avons hâte de vous partager la suite de nos avancées.✨ #Crowdfunding #Innovation #Merci
🤖 Made with AI
1
23
100% French research A game-changer in the fight against viruses—through the nose, not the arm. 👃❌💉 For the past four years, Lovaltech has been developing a groundbreaking vaccine to block transmission — not just severe cases. 🎂
1
1
3
31
🧬 Phase I validated | €17M raised | Phase II underway (results by late 2027). A 100% French breakthrough technology, proudly developed in the laboratories of the University of Tours and @INRAE_France. 🇫🇷🌱 #Deeptech #Vaccines #MucosalImmunity
1
2
25
🏁 Dernière ligne droite pour Lovaltech ! Objectifs dépassés avec +500 investisseurs mobilisés pour réinventer la vaccination par voie intranasale. Un immense merci. 🧬🔥 Pourquoi nous rejoindre avant la clôture ?
1
1
21
Pour nous donner les moyens de : 🧪 Valider notre Phase II clinique 💻 Accélérer notre plateforme R&D 🩺 Faire avancer le programme #COVIDLong 🤝 Négocier nos partenariats et licences avec la pharma
1
1
23
Notre mission : cibler les muqueuses pour réduire drastiquement la transmission des agents infectieux. Deadline pour investir ici ➡️ tdgo.co/5zo3lt #Innovation #Investissement #France2030
1
17
L’#Hantavirus est au cœur de l’actualité. Notre plateforme pourrait-elle servir de base pour un vaccin nasal ? 🤔 Si nos priorités restent le #COVIDLong, la grippe et la préparation pandémique, nos technologies sont prêtes à pivoter en cas d'urgence. 🧪
1
2
57
Décryptage dans @NR_Tours : 🔗 lanouvellerepublique.fr/tour… #HealthTech #Recherche #Deeptech
2
52
Heading toward the future! 📈 Lovaltech is nearing the end of @euronext's IPOready program following a memorable penultimate session at their offices in La Défense. A highlight of the event was the iconic symbol of going public: ringing the market bell. 🔔
1
1
45
A great preparation for a stronger future for Lovaltech! A big thank you to Euronext for the quality of their support throughout this demanding and inspiring journey. 👍 #IPOready #Euronext #StockMarket #Biotech
1
47
Why do we talk about global health (#OneHealth)? 🦠+🌱+👤 Because 75% of emerging human diseases originate in animals. Anticipating tomorrow’s needs requires looking at the living world as a whole. This is Lovaltech’s scientific compass. 🚀 #Biotech #Prevention #EcoHealth
1
40
The key to preventing transmission lies not in reacting, but in anticipating. 🌍 Unraveling the complexities of viral spread is at the heart of our mission.
1
1
38
Our teams tackle this technological challenge every day to develop more effective and sustainable protection. ✨ #Biotech #FutureOfHealth #Deeptech
🤖 Made with AI
1
33
Proud to embody local innovation! 🚀 On May 6th, the President of @lovaltech attended a private dinner with H.S.H. Prince Albert II of Monaco and the Prefect of Indre-et-Loire.
1
1
43
It was a key opportunity to showcase our major breakthrough : a nasal vaccine that blocks the transmission of viruses. 🧬🛡️ 🔜Next step: Monaco in September for a presentation to the local economic circle. #DeepTech #PrinceOfMonaco #Immunology
1
65
Long COVID is not inevitable; it is a major medical challenge. 🩺 In response to the lack of effective treatment for millions of patients, Lovaltech is taking action.
1
1
2
36
Together with our partners, we are developing a strategy based on mucosal immunity to address the root causes of persistent symptoms. Acting today for tomorrow’s health. ✨ #Innovation #HealthTech #LongCovid
1
1
49
🔍 Science Spotlight: Do you know about IgA? While traditional antibodies circulate in the blood, IgA antibodies are the true “guardians” of our mucous membranes—especially those in the nose. 🛡️
1
1
50
By stimulating their production right at the virus’s point of entry, Lovaltech aims to block transmission from the very first contact. No entry, no infection! 🚫🦠 #Lovaltech #Immunology #IgA #Innovation #Health
🤖 Made with AI
1
53
Load more